Consegna has sold its Linguet technology to Imugene; Intellipharmaceutics settles patent litigation with AstraZeneca;

> Consegna has sold its Linguet technology to Imugene in exchange for a 29% shareholding. Article

> Intellipharmaceutics has settled all outstanding patent litigation with AstraZeneca ($AZN) over the generic version of AZ's Seroquel XR, an extended-release formulation of quetiapine. Press release

> The FDA has accepted NuPathe's ($PATH) resubmission of Zelrix, its migraine patch; the target date for the FDA to complete its review of the NDA is Jan. 17. Press release

> BioAlliance Pharma has received a U.S. patent for Sitavig, a tablet that sticks to the upper gum and delivers acyclovir to treat recurrent cold sores (labial herpes). Article

> Laser-engineered dissolving microneedles could deliver nadroparin. Abstract

> BD Medical's new needle aims to improve performance and patient comfort. Press release

> Bio-Path has started enrollment of a fourth cohort of a Phase I trial of liposomal Grb-2 for leukemia. Press release

> Diabetology to develop oral insulin for India. Press release

And Finally… Alexza's ($ALXA) CEO has high expectations of receiving FDA approval for Adasuve, its inhaled antipsychotic. Article